Psilocybin can be produced de novo in yeast. The findings could help with the development of drugs that utilize the psychedelic compound to treat depression and other mental health disorders.
Researchers were able to produce 0.6 grams of ergothioneine, a natural amino acid that has promising effects on Alzheimer's disease in animal studies, per liter of yeast broth via a small scale fermentation process.
